Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 07.09.2026 4 Am J Clin Nutr 1 Am J Ophthalmol 3 Ann Intern Med 1 BMC Ophthalmol 1 BMC Pediatr 6 Diabet Med 2 Diabetes Care 31 Diabetes Obes Metab 7 Diabetologia 2 J Am Soc Nephrol 1 J Clin Endocrinol Metab 2 J Diabetes Complications 3 J Nutr 1 Lancet 1 Metabolism 1 Ophthalmol Retina 1 Pediatrics 1 PLoS Biol 6 PLoS One 1 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. SHI JL
   Letter to the Editor: Concerns on the comparative efficacy of carbohydrate quality index and newly developed alternate carbohydrate quality index for predicting type 2 diabetes.
   Am J Clin Nutr. 2026;124:101424.
   PubMed        
   
   
2. RASMUSSEN JLP, Gram-Kampmann EM, Stidsen JV, Hansen CD, et al
   Effect of a 6-month low-carbohydrate diet on the circulating fatty acid composition in patients with type 2 diabetes: a secondary analysis of an open-label randomized controlled trial.
   Am J Clin Nutr. 2026;124:101400.
   PubMed         Abstract available
   
   
3. QIU Z, Liu G, Liu B, Hu Y, et al
   Post-Diagnosis Healthy Dietary Patterns in Relation to All-Cause and Cause-Specific Mortality and Life Expectancy among Adults with Type 2 Diabetes: Evidence from Cohort Studies.
   Am J Clin Nutr. 2026 Aug 31:101510. doi: 10.1016/j.ajcnut.2026.101510.
   PubMed         Abstract available
   
   
4. NGUYEN TA, Nguyen NN, Nguyen HS, Linh TTD, et al
   Ultraprocessed food consumption and the global burden of noncommunicable disease: a 45-country comparative risk assessment.
   Am J Clin Nutr. 2026;124:101417.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

5. KUNDU R, Goturi N, Green M, Poulaki V, et al
   Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema.
   Am J Ophthalmol. 2026 Sep 4:S0002-9394(26)00504.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

6. 
   Summary for Patients: An Updated Systematic Review on Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes.
   Ann Intern Med. 2026 Sep 1. doi: 10.7326/ANNALS-25-05519.
   PubMed        
   
   
7. 
   Annals Video Summary - Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes.
   Ann Intern Med. 2026 Sep 1:e2603114VS. doi: 10.7326/ANNALS-26-03114.
   PubMed        
   
   
8. MOIZ A, Filion KB, Samuels AE, Tsoukas MA, et al
   Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.
   Ann Intern Med. 2026 Sep 1. doi: 10.7326/ANNALS-25-05519.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

9. FOROOZANFAR Z, Ghadiri-Anari A, Azizi R, Mehrabbeik A, et al
   Predictors of time to diabetic retinopathy in patients with type 2 diabetes mellitus: a survival analysis study.
   BMC Ophthalmol. 2026;26:528.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

10. ADELOYE AY, Oyenusi EE, Falokun IB, Utomi IL, et al
    Oral manifestations of endocrine disorders among patients attending the paediatric endocrinology clinic in the lagos university teaching hospital: a cross-sectional study.
    BMC Pediatr. 2026;26:824.
    PubMed         Abstract available
    
    

    
    Diabet Med

11. ATHANASIADOU KI, Jones C, Ovadia C, Banerjee A, et al
    Diabetic chronic kidney disease in women with pregestational diabetes and risk of pre-eclampsia.
    Diabet Med. 2026 Aug 28:e70470. doi: 10.1111/dme.70470.
    PubMed        
    
    
12. JONES HM, Alyafei L, Macro L, Gardener G, et al
    Physical activity during pregnancy in women with type 1 or type 2 diabetes: A scoping review.
    Diabet Med. 2026 Aug 28:e70452. doi: 10.1111/dme.70452.
    PubMed         Abstract available
    
    
13. JONES PM, Gatward S, Beadle L, Panizza A, et al
    PPI and researcher perspectives of islet transplantation therapy for type 1 diabetes.
    Diabet Med. 2026 Aug 29:e70456. doi: 10.1111/dme.70456.
    PubMed         Abstract available
    
    
14. MAHALINGASIVAM AA, Bech AA, Vestergaard P, Jorgensen MG, et al
    DiaActive protocol: A randomized controlled trial of cognitive-motor multicomponent exercise to reduce fall rate in older adults with diabetes.
    Diabet Med. 2026 Aug 30:e70461. doi: 10.1111/dme.70461.
    PubMed         Abstract available
    
    
15. AYIS S, Ozdede M, Gnudi L, Alobaid T, et al
    The role of sex and ethnicity in the variability of estimated glomerular filtration rate (eGFR) in people with type 1 diabetes.
    Diabet Med. 2026 Aug 31:e70469. doi: 10.1111/dme.70469.
    PubMed         Abstract available
    
    
16. ADISSA D, Makinson C, Elafros MA, Mizokami-Stout K, et al
    The effect of social determinants of health on use of diabetes-related mobile health applications in older adults with type 2 diabetes.
    Diabet Med. 2026 Sep 2:e70464. doi: 10.1111/dme.70464.
    PubMed         Abstract available
    
    

    
    Diabetes Care

17. ROSEN J, de Boer IH, Eckel RH, McGuire DK, et al
    SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.
    Diabetes Care. 2026 Sep 3:dc260999. doi: 10.2337/dc26-0999.
    PubMed         Abstract available
    
    
18. SIMS EK, You L, Ismail H, Evans-Molina C, et al
    beta-Cell Dysfunction Identifies Individuals With Single Autoantibody Positivity at Increased Risk of Type 1 Diabetes Progression.
    Diabetes Care. 2026 Sep 2:dc261111. doi: 10.2337/dc26-1111.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

19. LIU S, Zheng H, Tan JLI, Ang K, et al
    Pathway-Specific Polygenic Risk Score and Risk of Hyperglycaemic Progression in Patients With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71294.
    PubMed         Abstract available
    
    
20. GARG S, Kitchen R, Gupta R, Donnelly L, et al
    Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71262.
    PubMed         Abstract available
    
    
21. BAJAJ HS, Fischer M, Davidson MB, Tarafder AM, et al
    Insulin Efsitora Demonstrates Similar Efficacy and Safety Profiles to Insulin Icodec in Insulin-Experienced Individuals With Type 2 Diabetes Mellitus: Matching-Adjusted Indirect Comparisons of QWINT-3 Versus ONWARDS 2, and QWINT-4 Versus ONWARDS 4.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71272.
    PubMed         Abstract available
    
    
22. BROSEN JMB, Malmsio D, Divilly P, Martine-Edith G, et al
    Person-Reported and Continuous Glucose Monitoring (CGM) Recorded Hypoglycaemia in People With Insulin-Treated Type 2 Diabetes and Mild to Moderate Chronic Kidney Disease; Post Hoc Analysis From the Hypo-METRICS Study.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71247.
    PubMed         Abstract available
    
    
23. SMIDT MF, Wennberg P, Albers HM, Agyemang C, et al
    Evaluation of Diabetes Risk Models Applied to the Prediction of Incident Dysglycaemia in African and European Populations.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71285.
    PubMed         Abstract available
    
    
24. ECHOUFFO-TCHEUGUI JB, Liu X, Soliman EZ, Pi-Sunyer X, et al
    Dysglycaemia and Autonomic Dysfunction: The Diabetes Prevention Program Outcomes Study.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71111.
    PubMed         Abstract available
    
    
25. QAMAR F, Parveen R, Khan I, Sharma M, et al
    One Model, Many Phenotypes: The Urgent Need to Standardise the High-Fat Diet-Streptozotocin Model for Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71300.
    PubMed        
    
    
26. ISHIBASHI R, Hirayama K, Sakai T, Tatsumi T, et al
    Sodium-Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage-Dependent Systemic-Retinal Responsiveness.
    Diabetes Obes Metab. 2026 Sep 2. doi: 10.1111/dom.71295.
    PubMed         Abstract available
    
    
27. HARBI H, Thomsen RW, Lundby C, Stidsen JV, et al
    Use of Glucose-Lowering Drugs for Type 2 Diabetes Among Danish Care Home Residents.
    Diabetes Obes Metab. 2026 Sep 3. doi: 10.1111/dom.71308.
    PubMed         Abstract available
    
    
28. ISHAK N, Eddy Warman N'A, Raja Shariff REF, Chen XW, et al
    The Association Between NT-Pro BNP, Nephropathy and Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71258.
    PubMed         Abstract available
    
    
29. MUK T, Okdahl T, Kokla M, Suvitaival T, et al
    Serum Lipidomics Profiling Identify Novel Biomarkers of Distal Symmetrical Polyneuropathy in Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71257.
    PubMed         Abstract available
    
    
30. MOHAMED IA, Sequeira-Bisson IR, Lim JJ, Plank LD, et al
    Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial.
    Diabetes Obes Metab. 2026 Sep 1. doi: 10.1111/dom.71270.
    PubMed         Abstract available
    
    
31. MONTASER E, Bhasin K, Kruger D, Akturk HK, et al
    Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study.
    Diabetes Obes Metab. 2026 Aug 31. doi: 10.1111/dom.71287.
    PubMed         Abstract available
    
    
32. GALE JT, Hargreaves EA, Haszard JJ, Peddie MC, et al
    An Evening Activity Breaks Intervention for Improvement of Glucose, Blood Pressure, and Sleep: A Pilot Study in Free-Living Adults.
    Diabetes Obes Metab. 2026;28:9552-9562.
    PubMed         Abstract available
    
    
33. MALKIN SJP, Kandalam S, Guareschi G, D'Angiolella LS, et al
    Projecting the Long-Term Cost-Effectiveness of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogs in Italy Using the Prime T2D Model.
    Diabetes Obes Metab. 2026;28:9483-9492.
    PubMed         Abstract available
    
    
34. SHAO C, Lin H, Yu J, Chen H, et al
    Efficacy and Safety of Bimagrumab in Adults With Obesity and Metabolic Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Diabetes Obes Metab. 2026;28:9433-9442.
    PubMed         Abstract available
    
    
35. NOMA H, Yamazaki H, Sunada H, Oda F, et al
    Sustained Use of SGLT2 Inhibitors and Cardiovascular Outcomes in Older Adults: A Landmark Cohort Study.
    Diabetes Obes Metab. 2026;28:9385-9394.
    PubMed         Abstract available
    
    
36. BEA S, Lee H, Cho YM, Choi YJ, et al
    Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone.
    Diabetes Obes Metab. 2026;28:9336-9345.
    PubMed         Abstract available
    
    
37. ZHANG W, Wang Y, Li X, Peng L, et al
    Joint Trajectories of Physical Activity and Depressive Symptoms and Incident Cardiometabolic Multimorbidity: A Multi-Cohort Study.
    Diabetes Obes Metab. 2026;28:9210-9221.
    PubMed         Abstract available
    
    
38. DAMGAARD M, Kokla M, Gerwig RH, Mizrak HI, et al
    Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory Cytokines.
    Diabetes Obes Metab. 2026;28:8847-8860.
    PubMed         Abstract available
    
    
39. CHEN SC, Wang TJ, Chou CK, Lee C, et al
    Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists.
    Diabetes Obes Metab. 2026;28:8895-8904.
    PubMed         Abstract available
    
    
40. KIM M, Park E
    Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU: A Retrospective Cohort Study.
    Diabetes Obes Metab. 2026;28:8870-8877.
    PubMed         Abstract available
    
    
41. OLDENBURG LIK, Haugaard SP, Karlsson T, Kegel-Hubner V, et al
    Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of Zenagamtide.
    Diabetes Obes Metab. 2026;28:8946-8954.
    PubMed         Abstract available
    
    
42. GUO X, Zhang J, Li Q, Ye Z, et al
    Safety Profile of Tirzepatide in Real-World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database.
    Diabetes Obes Metab. 2026;28:8936-8945.
    PubMed         Abstract available
    
    
43. FALK H, Aaltio A, Pulkkinen MA, Varimo T, et al
    Comparison of Diluted Insulin (U10) Versus Standard (U100) Insulin in Automated Insulin Delivery Systems: Reducing Time Below Range in Young Children.
    Diabetes Obes Metab. 2026;28:8966-8973.
    PubMed         Abstract available
    
    
44. ATHINARAYANAN SJ, Bjornstad P, Shanmugam PV, Weimbs T, et al
    Effectiveness of Telehealth Low-Carbohydrate Intervention in Preventing Chronic Kidney Disease: A Real-World, Retrospective, Matched Cohort Study.
    Diabetes Obes Metab. 2026;28:9054-9068.
    PubMed         Abstract available
    
    
45. CHEN X, Xi Q, Jin Y, Fang P, et al
    Association of Maternal Overweight/Obesity Metabolic Phenotypes With Longitudinal Foetal Anthropometric Measurements.
    Diabetes Obes Metab. 2026;28:9080-9090.
    PubMed         Abstract available
    
    
46. MARIGLIANO M, Piona C, Morotti E, Macedoni M, et al
    Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition.
    Diabetes Obes Metab. 2026;28:9178-9187.
    PubMed         Abstract available
    
    
47. XU S
    Safety Signals of GLP-1 Receptor Agonists: A Multi-Method Pharmacovigilance Analysis of FAERS (2018-2025) With Sensitivity-Stratified Prioritisation, Notoriety-Bias Assessment, and Cross-Database Validation.
    Diabetes Obes Metab. 2026;28:9251-9264.
    PubMed         Abstract available
    
    
48. REN L, Zhang Y, Fang F, Ma Y, et al
    Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.
    Diabetes Obes Metab. 2026 Sep 3. doi: 10.1111/dom.71303.
    PubMed         Abstract available
    
    
49. ZHAO S, Dao GM, Schofield C, Vogrin S, et al
    Pre-Bedtime Whey Protein Ingestion Increases Blood Glucose Overnight in Adults With Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Sep 3. doi: 10.1111/dom.71307.
    PubMed        
    
    

    
    Diabetologia

50. SANDFORTH L, Veit R, Machann J, Dannecker C, et al
    Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity.
    Diabetologia. 2026;69:2957-2969.
    PubMed         Abstract available
    
    
51. ROGERS NM, Hu M, Jimenez-Vera E, Gabor H, et al
    A multi-centre study of belatacept and sirolimus for islet transplantation.
    Diabetologia. 2026;69:2847-2861.
    PubMed         Abstract available
    
    
52. CHOKSI H, Klein Nulend R, Cooper T, Au E, et al
    Metabolic and macrovascular outcomes following simultaneous pancreas-kidney transplantation and kidney transplantation alone in recipients with type 1 diabetes mellitus: a systematic review and meta-analysis.
    Diabetologia. 2026 Aug 29. doi: 10.1007/s00125-026-06843.
    PubMed         Abstract available
    
    
53. MCCLURE RD, Boule NG, Yardley JE
    Exercise timing or feeding status? Interpreting glycaemic responses to resistance exercise in type 1 diabetes. Reply to Gray S, Al-Awadhi A, Al-Ozairi E [letter].
    Diabetologia. 2026 Aug 29. doi: 10.1007/s00125-026-06851.
    PubMed        
    
    
54. LUCKETT AM, McGrail C, Murrall K, Griffin EN, et al
    Genetic association stratified by HLA-DR3 and HLA-DR4 status reveals heterogeneity in pathways of progression to type 1 diabetes.
    Diabetologia. 2026 Aug 31. doi: 10.1007/s00125-026-06836.
    PubMed         Abstract available
    
    
55. GRAY SR, Al-Awadhi A, Al Ozairi E
    Exercise timing or feeding status? Interpreting glycaemic responses to resistance exercise in type 1 diabetes.
    Diabetologia. 2026 Aug 31. doi: 10.1007/s00125-026-06850.
    PubMed        
    
    
56. XIE X, Wu C, Luo X, Wei Y, et al
    Single-cell profiling of pancreatic islets maps subtype-associated molecular alterations in type 2 diabetes.
    Diabetologia. 2026 Sep 1. doi: 10.1007/s00125-026-06842.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

57. AGARWAL R, Correa-Rotter R, Navaneethan SD, Fukami K, et al
    Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.
    J Am Soc Nephrol. 2026;37:1969-1978.
    PubMed         Abstract available
    
    
58. CATANESE B, Miller C, Wolf M, Edmonston D, et al
    Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.
    J Am Soc Nephrol. 2026;37:1992-2003.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

59. MORI R, Kaga H, Someya Y, Naito H, et al
    Associations of diabetes status and physical activity with cognitive impairment and hippocampal volume in older adults.
    J Clin Endocrinol Metab. 2026 Aug 31:dgag357. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

60. GEORGIOU C, Bistola V, Karavidas A, Vassilikos VP, et al
    Prevalence and evolution of heart failure in patients with type 2 diabetes mellitus at high cardiovascular risk (HF-LANDMARK study).
    J Diabetes Complications. 2026;40:109396.
    PubMed         Abstract available
    
    
61. GULLAKSEN S, Vernstrom L, Sorensen SS, Funck KL, et al
    Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.
    J Diabetes Complications. 2026;40:109397.
    PubMed         Abstract available
    
    

    
    J Nutr

62. TOMIGA Y, Hayashi N, Kusano M, Ito A, et al
    Neuronal Nitric Oxide Synthase (nNOS) Expression Is Reduced in Skeletal Muscle from db/db Mice and Glucose and Fatty Acids Show Differential Effects on nNOS Regulation and Myogenic Differentiation.
    J Nutr. 2026;156:101726.
    PubMed         Abstract available
    
    
63. SCOTT CE, Adams CG, Williamson P, Hutton TK, et al
    Acute Stevia Consumption does not Alter Endocrine Responses in Individuals with Normal Weight, Overweight, and Type 2 Diabetes Mellitus.
    J Nutr. 2026 Sep 1:101814. doi: 10.1016/j.tjnut.2026.101814.
    PubMed         Abstract available
    
    
64. ZHANG S, Borne Y, Xu X, Gu Y, et al
    Habitual taurine intake and plasma taurine concentration are not associated with the risk of incident type 2 diabetes.
    J Nutr. 2026 Sep 4:101818. doi: 10.1016/j.tjnut.2026.101818.
    PubMed         Abstract available
    
    

    
    Lancet

65. PABON MA, Smith G, Sharma G, Catov J, et al
    Adverse pregnancy outcomes and long-term cardiovascular disease risk.
    Lancet. 2026;408:952-968.
    PubMed         Abstract available
    
    

    
    Metabolism

66. GONI L, Fernandez-Duval G, Razquin C, Toledo E, et al
    Oxidative balance-related metabolite signature and incident cardiovascular disease and type 2 diabetes within the PREDIMED trial.
    Metabolism. 2026 Sep 2:156763. doi: 10.1016/j.metabol.2026.156763.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

67. LEE JJ, Brothers T, Kim LA, Ward KE, et al
    GLP1-RA Use and Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes.
    Ophthalmol Retina. 2026 Sep 3:S2468-6530(26)00435.
    PubMed         Abstract available
    
    

    
    Pediatrics

68. ZHOU Z, Ling P, Tang R, Chen Y, et al
    Continuous Renal Replacement Therapy for Cytokine Storm in Diabetic Kawasaki Shock Syndrome.
    Pediatrics. 2026 Sep 2:e2025075282. doi: 10.1542/peds.2025-075282.
    PubMed         Abstract available
    
    

    
    PLoS Biol

69. RAN J, Wei C, Yang Y, Zhang Y, et al
    Hyperglycemic stress aggravates diabetic retinopathy and nephropathy by promoting cilium disassembly via a deacetylation- and methylation-mediated regulatory mechanism.
    PLoS Biol. 2026;24:e3003975.
    PubMed         Abstract available
    
    

    
    PLoS One

70. LI N, Ma Q, Fan X, Liu Q, et al
    EIF1 coordinates transcriptomic and splicing networks associated with cell cycle dysregulation in diabetic retinopathy.
    PLoS One. 2026;21:e0355473.
    PubMed         Abstract available
    
    
71. SHRESTHA R, Adhikari C, Shrestha MK, Paneru DP, et al
    Effect of school health nurse-supported child-to-family strategy for Diabetic Retinopathy prevention in Bhimeshwor Municipality of Bagmati Province, Nepal: A quasi-experimental study.
    PLoS One. 2026;21:e0357023.
    PubMed         Abstract available
    
    
72. ERINC A, Kirac A, Altun Acar FE, Onal AC, et al
    Association between triglyceride-glucose index and all-cause mortality in non-diabetic patients with fibrotic lung disease receiving antifibrotic therapy: A retrospective cohort study.
    PLoS One. 2026;21:e0357706.
    PubMed         Abstract available
    
    
73. 
    Retraction: Early expression of osteopontin glycoprotein on the ocular surface and in tear fluid contributes to ocular surface diseases in type 2 diabetic mice.
    PLoS One. 2026;21:e0357314.
    PubMed        
    
    
74. RASTOLDO G, Chirpaz A, Treport S, Gamin AY, et al
    Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model.
    PLoS One. 2026;21:e0356285.
    PubMed         Abstract available
    
    
75. O'REILLY SL, McDonnell T, Reme Sagedal L, Bermudez MG, et al
    Bump2Baby & Me+ (B2B&Me+): Protocol for a multi-country, European hybrid type 3 implementation-effectiveness study to reduce the incidence of gestational diabetes mellitus and improve maternal and child health.
    PLoS One. 2026;21:e0354394.
    PubMed         Abstract available
    
    

    
    Retina

76. MEHTA N, Hubbard GB
    Treatment of foveal-involving tractional retinal detachments from proliferative diabetic retinopathy with intravitreal anti-VEGF therapy.
    Retina. 2026 Aug 31. doi: 10.1097/IAE.0000000000005004.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum